logo-loader
viewSpotify Technology SA

Investors stream into Spotify; shares surge 25% in US trading debut

NYSE's Twitter account followed the IPO closely, sending out multiple tweets as the stock price rose

Man climbing stock on the rise
NYSE President Tom Farley weighed in on Twitter

Spotify Technology SA (NYSE: SPOT), the music-streaming subscription service, made its US market debut Tuesday as investors streamed in to turn up the volume on its share price.

The Swedish company opened trading on the New York Stock Exchange under the ticker "SPOT" and shares surged 25% above their reference price to US$165.90.

In lieu of a traditional initial public offering, the company listed directly to the market with what's called a reference price of $132 per share. That values the company at US$30bln.

READ: Spotify CEO keeping a low profile as streaming music service goes public

The NYSE posted real-time updates on Twitter. Tom Farley, president of the NYSE, tweeted his take on Spotify’s IPO.

Spotify currently has more than 157 million users in 65 countries, including 71 million Spotify Premium subscribers, according to the company’s press release. Spotify Premium, an ad-free version of the service, costs $9.99 a month.

Music legend Gene Simmons of KISS appeared on CNBC’s “Squawk on the Street” to share a musician’s perspective on the IPO. While Simmons praised the company and its management, he expressed concern about the way streaming has short-changed artists and the lack of regulations.

READ: Rock legend and Kiss star Gene Simmons joins Invictus MD Strategies as it opens trade in Toronto

“Artists have gotten the rug pulled out from under them and I’m shocked that the legislators in Washington D.C. haven’t taken the entire industry to task,” said Simmons.

Quick facts: Spotify Technology SA

Price: 141.8 USD

NYSE:SPOT
Market: NYSE
Market Cap: $26.14 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Empower Clinics looking to attack opioid crisis with...

Empower Clinics (CSE:CBDT-OTC: EPWCF) Chairman and CEO Steven McAuley joined Steve Darling from Proactive in Toronto to discuss the company creating a division focussing on psilocybin and psychedelics aka magic mushrooms. McAuley telling Proactive how key this may become considering the...

13 hours, 52 minutes ago

2 min read